IntroductionHypertensive diseases are one of the most frequent medical complications in pregnancy, and the main reasons of maternal, fetal, and neonatal morbidity and mortality [1]. Preeclampsia is a systemic disease of pregnancy with hypertension, proteinuria, and edema, which affects the fetus because of utero-placental deficiency, that leads to growth retardation [2]. Preeclampsia is reported in approximately 2-8% of pregnancies. The incidence may vary according to race, region, and country [3]. The etiology of preeclampsia is still uncertain. Diabetes mellitus, kidney disease, obesity, ABSTRACTObjectives: Preeclampsia is a major cause of maternal, fetal and neonatal morbidity and mortality. The aim of this study was to determine neonatal outcomes of premature infants born to preeclamptic mothers.Patients and Methods: Preterm infants ≤36 gestational age who were born to preeclamptic mothers and normotensive mothers were included in this study. Infant's data including demographic characteristics, neonatal morbidities and mortalities were evaluated retrospectively.Results: Hundred and forty infants born to preeclamptic mothers (study group) and 144 infants born to normotensive mothers (control group) were included. No statistical difference was found between mean gestational age, birth weight, Apgar scores at 1 and 5 minutes, and in terms of sex ratio. Cesarean delivery, small gestational age and neutropenia rates were found significantly higher in the study group. Other neonatal morbidities such as necrotising enterocolitis and sepsis were also found higher in the study group but it was not statistically significant. Hospitalization and mortality rates were similar in both groups.Conclusions: Preeclampsia was associated with increased cesarean delivery, small gestational age and neutropenia. There were no significant differences between other morbidities and mortality of two groups. We think that prematurity is the main risk factor of morbidity and mortality regardless of concomitant.
The aim of this study was to evaluate the aetiology of chest pain, the demographic data of patients with chest pain, and the effect of the coronavirus disease 2019 (COVID-19) pandemic on these variables. Material and Method:The study included patients who presented with complaints of chest pain at a paediatric cardiology policlinic between November 2019 and August 2020. The patients were divided into two groups based on the date 11 March 2020, when restrictions to daily life were implemented because of the COVID-19 pandemic in Turkey. Groups 1 and 2 included patients who presented with chest pain before and after that date, respectively.Results: Evaluations were made in 251 patients comprising 136 (54.2%) females and 115 (45.8%) males with a mean age of 11.6±2.9 years. The chest pain was felt most often in the precordial area (46.2%) as a needle pricking sensation (64.9%). The most causes of the chest pain were determined to be the musculoskeletal system (55%), psychogenic (16.3%), and idiopathic (13.5%), respectively. A cardiac aetiology was determined in 2.8% of the patients. Psychogenic reasons were more prevalent, and more patients had been referred by a physician and from rural areas,in Group 2 than Group 1 (p<0.05). Conclusion:To prevent repeated policlinic presentations with non-cardiac chest pain, and unnecessary and lengthy tests, the concerns of families must be eliminated. Since the beginning of the COVID-19 pandemic, the number of children with chest pain of psychogenic cause has increased.
Central hematocrit levels in malnourished term AGA neonates were found significantly higher than well-nourished term AGA newborns.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.